Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1968 1
1972 1
1975 1
1976 3
1977 1
1980 1
1982 1
1983 1
1986 1
1987 1
1988 1
1989 1
1990 4
1991 5
1992 4
1993 4
1994 2
1995 7
1996 9
1997 17
1998 14
1999 16
2000 28
2001 33
2002 48
2003 63
2004 65
2005 79
2006 95
2007 71
2008 105
2009 111
2010 134
2011 171
2012 168
2013 201
2014 195
2015 211
2016 219
2017 227
2018 257
2019 283
2020 265
2021 265
2022 110
Text availability
Article attribute
Article type
Publication date

Search Results

3,140 results
Results by year
Filters applied: . Clear all
Page 1
RAB31 marks and controls an ESCRT-independent exosome pathway.
Wei D, Zhan W, Gao Y, Huang L, Gong R, Wang W, Zhang R, Wu Y, Gao S, Kang T. Wei D, et al. Among authors: kang t. Cell Res. 2021 Feb;31(2):157-177. doi: 10.1038/s41422-020-00409-1. Epub 2020 Sep 21. Cell Res. 2021. PMID: 32958903 Free PMC article.
Necroptosis microenvironment directs lineage commitment in liver cancer.
Seehawer M, Heinzmann F, D'Artista L, Harbig J, Roux PF, Hoenicke L, Dang H, Klotz S, Robinson L, Doré G, Rozenblum N, Kang TW, Chawla R, Buch T, Vucur M, Roth M, Zuber J, Luedde T, Sipos B, Longerich T, Heikenwälder M, Wang XW, Bischof O, Zender L. Seehawer M, et al. Among authors: kang tw. Nature. 2018 Oct;562(7725):69-75. doi: 10.1038/s41586-018-0519-y. Epub 2018 Sep 12. Nature. 2018. PMID: 30209397 Free PMC article.
Targeting the CK1α/CBX4 axis for metastasis in osteosarcoma.
Wang X, Qin G, Liang X, Wang W, Wang Z, Liao D, Zhong L, Zhang R, Zeng YX, Wu Y, Kang T. Wang X, et al. Among authors: kang t. Nat Commun. 2020 Feb 28;11(1):1141. doi: 10.1038/s41467-020-14870-4. Nat Commun. 2020. PMID: 32111827 Free PMC article.
Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform.
Chiuppesi F, Salazar MD, Contreras H, Nguyen VH, Martinez J, Park Y, Nguyen J, Kha M, Iniguez A, Zhou Q, Kaltcheva T, Levytskyy R, Ebelt ND, Kang TH, Wu X, Rogers TF, Manuel ER, Shostak Y, Diamond DJ, Wussow F. Chiuppesi F, et al. Among authors: kang th. Nat Commun. 2020 Nov 30;11(1):6121. doi: 10.1038/s41467-020-19819-1. Nat Commun. 2020. PMID: 33257686 Free PMC article.
Targeting enhancer reprogramming to mitigate MEK inhibitor resistance in preclinical models of advanced ovarian cancer.
Liu S, Zou Q, Chen JP, Yao X, Guan P, Liang W, Deng P, Lai X, Yin J, Chen J, Chen R, Yu Z, Xiao R, Sun Y, Hong JH, Liu H, Lu H, Chen J, Bei JX, Koh J, Chan JY, Wang B, Kang T, Yu Q, Teh BT, Liu J, Xiong Y, Tan J. Liu S, et al. Among authors: kang t. J Clin Invest. 2021 Oct 15;131(20):e145035. doi: 10.1172/JCI145035. J Clin Invest. 2021. PMID: 34464356 Free PMC article.
3,140 results